Sol-Gel Technologies Ltd operates as a clinical stage pharmaceutical company. The Company identifies and develops topical dermatological drug products for the treatment of skin diseases. Sol-Gel Technologies markets its products worldwide.
SeekingAlpha
CNBC
CNBC
MarketWatch
Access detailed stock analysis from LSEG including analyst price target estimates.